Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.024
Neutral
RSI(14)
53.662
Neutral
STOCH(KDJ)(9,3,3)
53.838
Neutral
ATR(14)
0.051
Low Volatility
CCI(14)
110.874
Buy
Williams %R
41.445
Buy
TRIX(12,20)
-0.105
Sell
StochRSI(14)
80.651
Buy
IRIDEX Corp
IRIX1.000USD
+0.030+3.09%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
17.05MMarket Cap
LossP/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of IRIDEX Corp
Currency: USD Updated: 2025-12-19Key Insights
IRIDEX Corp's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 150/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.In the medium term, the stock price is expected to remain stable.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
IRIDEX Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
0.000
Target Price
0.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
IRIDEX Corp Highlights
StrengthsRisks
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Growing
The company is in a growing phase, with the latest annual income totaling USD 48.67M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 48.67M.
Fairly Valued
The company’s latest PE is -3.32, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 2.61M shares, decreasing 16.95% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 389.06K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 0.39.
Financial Health
Currency: USD Updated: 2025-12-19The current financial score of IRIDEX Corp is 6.21, ranking 167/208 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 12.48M, representing a year-over-year increase of 7.80%, while its net profit experienced a year-over-year increase of 18.62%.
Score
Financials
6.55
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
6.24
Operational Efficiency
5.91
Growth Potential
5.28
Shareholder Returns
7.07
IRIDEX Corp's Company Valuation
Currency: USD Updated: 2025-12-19The current valuation score of IRIDEX Corp is 8.37, ranking 27/208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -3.32, which is -56.08% below the recent high of -1.46 and -104.84% above the recent low of -6.80.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 150/208
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2025-12-19No earnings forecast score is currently available for IRIDEX Corp. The Healthcare Equipment & Supplies industry's average is 7.77.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
No Data
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-12-19The current price momentum score of IRIDEX Corp is 6.82, ranking 108/208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 1.08 and the support level at 0.91, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
0.991
Buy
MA10
0.962
Buy
MA20
0.948
Buy
MA50
1.000
Buy
MA100
1.122
Sell
MA200
1.085
Sell
Institutional Confidence
Currency: USD Updated: 2025-12-19The current institutional shareholding score of IRIDEX Corp is 3.00, ranking 135/208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 15.39%, representing a quarter-over-quarter decrease of 65.93%. The largest institutional shareholder is The Vanguard, holding a total of 578.71K shares, representing 3.37% of shares outstanding, with 4.97% decrease in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
Topcon Corp
Stanley Manne Trust
Paragon JV Partners, LLC
Roland (Brent Alexander)
Moore (William M)
Roland Family Support Trust
AMH Equity, Ltd.
Roland (Glenn Cuthbert)
1
2
Risk Assessment
Currency: USD Updated: 2025-12-19The current risk assessment score of IRIDEX Corp is 2.73, ranking 147/208 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.55. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Score
Beta vs S&P 500 index
0.55
VaR
+5.72%
240-Day Maximum Drawdown
+56.11%
240-Day Volatility
+84.39%
Return
Best Daily Return
60 days
+10.43%
120 days
+20.56%
5 years
+34.04%
Worst Daily Return
60 days
-19.82%
120 days
-19.82%
5 years
-34.76%
Sharpe Ratio
60 days
-0.72
120 days
+0.72
5 years
-0.28
Risk Assessment
Maximum Drawdown
240 days
+56.11%
3 years
+77.62%
5 years
+91.57%
Return-to-Drawdown Ratio
240 days
-0.73
3 years
-0.25
5 years
-0.19
Skewness
240 days
+0.30
3 years
+0.16
5 years
+0.35
Volatility
Realised Volatility
240 days
+84.39%
5 years
+79.33%
Standardised True Range
240 days
+7.68%
5 years
+18.39%
Downside Risk-Adjusted Return
120 days
+103.18%
240 days
+103.18%
Maximum Daily Upside Volatility
60 days
+51.87%
Maximum Daily Downside Volatility
60 days
+58.71%
Liquidity
Average Turnover Rate
60 days
+0.70%
120 days
+0.66%
5 years
--
Turnover Deviation
20 days
+38.63%
60 days
+80.69%
120 days
+70.89%
Peer Comparison
Healthcare Equipment & Supplies
IRIDEX Corp
IRIX
4.74 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Edwards Lifesciences Corp
EW
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LIVN
8.59 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Artivion Inc
AORT
8.59 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
LNTH
8.57 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Tactile Systems Technology Inc
TCMD
8.43 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
FAQs
How does TradingKey generate the Stock Score of IRIDEX Corp?
The TradingKey Stock Score provides a comprehensive assessment of IRIDEX Corp based on 34 indicators derived from over 100 underlying data points. These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of IRIDEX Corp’s performance and outlook.
How do we generate the financial health score of IRIDEX Corp?
To generate the financial health score of IRIDEX Corp, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns. By integrating these comprehensive data, the financial health score not only reflects IRIDEX Corp's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of IRIDEX Corp.
How do we generate the company valuation score of IRIDEX Corp?
To generate the company valuation score of IRIDEX Corp, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare IRIDEX Corp’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value. By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of IRIDEX Corp’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of IRIDEX Corp.
How do we generate the earnings forecast score of IRIDEX Corp?
To calculate the earnings forecast score of IRIDEX Corp, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.Comparing these indicators against peers provides context for the stock’s performance and helps
anchor more realistic expectations.These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on IRIDEX Corp’s future.
How do we generate the price momentum score of IRIDEX Corp?
When generating the price momentum score for IRIDEX Corp, we examine momentum indicators including support and resistance levels as well as volume metrics.Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.This comprehensive approach can reflect market sentiment and enable rational forecasts of IRIDEX Corp’s prices. A higher score indicates a more stable short-term price trend for IRIDEX Corp.
How do we generate the institutional confidence score of IRIDEX Corp?
To generate the institutional confidence score of IRIDEX Corp, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about IRIDEX Corp’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of IRIDEX Corp.
How do we generate the risk management score of IRIDEX Corp?
To assess the risk management score of IRIDEX Corp, we examine multiple key indicators related to returns, risk, volatility, and liquidity.The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.These indicators together provide a multi-dimensional understanding of IRIDEX Corp’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of IRIDEX Corp.
